person · Reporting owner

Malha Pedro Bruno Ferreira

Disclosed activity across 1 company

Tapewire entity: 56404
SEC CIK: 0002085385

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
SkinHealth Systems Inc.SKIN · Entity 6863	Director · President and CEO	October 09, 2026	October 13, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

SkinHealth Systems Inc.

Report date October 09, 2026 · Filed October 13, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	4,667,464	Ending reported balance After 2026-10-09 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-10-09 · Tax withholding · Disposed 99,742 · Balance 4,745,509 F1: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale. Row 2 · 2026-10-09 · Tax withholding · Disposed 78,045 · Balance 4,667,464 F1: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
October 09, 2026 Filed Oct 13, 2026 20:14 UTC	SkinHealth Systems Inc. SKIN · Entity 6863	Tax withholdingClass A Common Stock	78,045	$0.55	$42,924.75	Disclosure SEC source: 0001628280-26-065692 · wk-form4_1791922458.xml · nonDerivative · entry 2 Malha Pedro Bruno Ferreira · CIK 0002085385 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,667,464 F1 · kind: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale. Read SEC document
October 09, 2026 Filed Oct 13, 2026 20:14 UTC	SkinHealth Systems Inc. SKIN · Entity 6863	Tax withholdingClass A Common Stock	99,742	$0.55	$54,858.10	Disclosure SEC source: 0001628280-26-065692 · wk-form4_1791922458.xml · nonDerivative · entry 1 Malha Pedro Bruno Ferreira · CIK 0002085385 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,745,509 F1 · kind: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale. Read SEC document
March 20, 2026 Filed Mar 24, 2026 21:06 UTC	SkinHealth Systems Inc. SKIN · Entity 6863	GrantClass A Common Stock	2,654,867	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-26-020850 · wk-form4_1774386383.xml · nonDerivative · entry 1 Malha Pedro Bruno Ferreira · CIK 0002085385 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,845,251 F1 · kind: Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock of The Beauty Health Company (the "Company"). The RSUs are subject to time-vesting conditions. The RSUs vest in one-third increments on each of the first three anniversaries of the grant date of March 20, 2026, in each case subject to continued service with the Company through the vesting date and certain acceleration rights. F1 · price: Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock of The Beauty Health Company (the "Company"). The RSUs are subject to time-vesting conditions. The RSUs vest in one-third increments on each of the first three anniversaries of the grant date of March 20, 2026, in each case subject to continued service with the Company through the vesting date and certain acceleration rights. Read SEC document
October 09, 2025 Filed Oct 10, 2025 20:32 UTC	SkinHealth Systems Inc. SKIN · Entity 6863	GrantClass A Common Stock	961,538	$1.56	$1,499,999.28	Disclosure SEC source: 0001628280-25-044806 · wk-form4_1760128373.xml · nonDerivative · entry 2 Malha Pedro Bruno Ferreira · CIK 0002085385 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,190,384 F1 · kind: Represents a grant of restricted stock units that vest in one-third increments on each of the first three anniversaries of the grant date of October 9, 2025, in each case subject to continued service through the vesting date and certain acceleration rights. Read SEC document
October 09, 2025 Filed Oct 10, 2025 20:32 UTC	SkinHealth Systems Inc. SKIN · Entity 6863	GrantClass A Common Stock	1,228,846	$1.56	$1,916,999.76	Disclosure SEC source: 0001628280-25-044806 · wk-form4_1760128373.xml · nonDerivative · entry 1 Malha Pedro Bruno Ferreira · CIK 0002085385 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,228,846 F1 · kind: Represents a grant of restricted stock units that vest in one-third increments on each of the first three anniversaries of the grant date of October 9, 2025, in each case subject to continued service through the vesting date and certain acceleration rights. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.